← Leaderboards
Pengyue Zhang
Ohio State University
$2,541,060
Attributed
$5,349,464
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,349,464 · 4
By mechanism
R01$5,349,464 · 4
Top collaborators
- Jing Su5 shared
- Macarius M. Donneyong4 shared
- Ping Zhang3 shared
- Feixiong Cheng1 shared
- Andrew J Saykin1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Macarius M. Donneyong$2,664,701
- Jessie L.-S. Au$10,705,345
- M Guillaume Wientjes$5,257,664
- Michael George Aman$6,533,883
- Amy K Ferketich$6,196,621
Others in their field
Other Emerging Leaders on “Drug Usage”
- Xinhua Li · Nano Terra, Inc.$18,050,370
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- Torri D Metz · University Of Utah$9,200,837
- Gonul Velicelebi · Sanford Burnham Prebys Medical Discovery Institute$8,970,452
- John E Schulenberg · University Of Michigan At Ann Arbor$8,135,202
Research focus
Drug UsagePharmaceutical PreparationsIndianaElectronic Health RecordDatabasesDrug CombinationsRisk FactorsPreventComorbidityDrug InteractionsOmeprazoleFluconazoleNovel TherapeuticsMyopathyInsurance ClaimsClonidineAdverse Drug EventPatient SafetyCharacteristicsAdultDiagnosisTreatment OutcomeCause Of DeathAdverse Event
Grant awards (13)
A Multimodal, Multiscale and Multistage Systems Biology (M3SB) Infrastructure for Precision Medicine in Alzheimerâs Disease and Longevity$802,034
R01 · FY2025 · AG
Significant high order drug interactions in the emergency department setting among older patient population$514,240
R01 · FY2025 · AG
Revealing Health Trajectories of Chronic Kidney Disease for Precision Medicine$328,713
R01 · FY2025 · LM
Significant high order drug interactions in the emergency department setting among older patient population$537,213
R01 · FY2024 · AG
Revealing Health Trajectories of Chronic Kidney Disease for Precision Medicine$328,949
R01 · FY2024 · LM
Significant high order drug interactions in the emergency department setting among older patient population$526,901
R01 · FY2023 · AG
Revealing Health Trajectories of Chronic Kidney Disease for Precision Medicine$336,129
R01 · FY2023 · LM
Revealing Health Trajectories of Chronic Kidney Disease for Precision Medicine$329,178
R01 · FY2023 · LM
A Statistical Network Pharmacology Approach for Early Detection of Adverse Drug Events$302,027
R01 · FY2023 · GM
Significant high order drug interactions in the emergency department setting among older patient population$379,321
R01 · FY2022 · AG
Revealing Health Trajectories of Chronic Kidney Disease for Precision Medicine$329,401
R01 · FY2022 · LM
A Statistical Network Pharmacology Approach for Early Detection of Adverse Drug Events$307,130
R01 · FY2022 · GM
A Statistical Network Pharmacology Approach for Early Detection of Adverse Drug Events$328,228
R01 · FY2021 · GM